Page last updated: 2024-12-07

o(4)-ethylthymidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O(4)-ethylthymidine: accumulates in hepatocyte DNA of rats exposed to diethylnitrosamine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107988
MeSH IDM0095566

Synonyms (10)

Synonym
4-o-ethylthymidine
59495-22-6
4-ethoxy-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one
o(4)-ethylthymidine
thymidine, 4-o-ethyl-
2(1h)-pyrimidinone, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-4-ethoxy-5-methyl-
o(4)-ethyldeoxythymidine
o(4)-ethyl-2'-deoxythymidine
1-(2-deoxypentofuranosyl)-4-ethoxy-5-methylpyrimidin-2(1h)-one
DTXSID20974895

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Therefore, we have begun to quantify the dose-response relationships for N-nitrosodiethylamine (NDEA)-induced hepatocarcinogenesis by characterizing the major promutagenic DNA adduct, O4-ethyldeoxythymidine (O4-etdT); hepatocyte proliferation; and hepatocyte initiation in rats continually exposed to drinking-water containing NDEA."( Molecular dosimetry of DNA alkylation during chronic exposure to carcinogens.
Boucheron, JA; Deal, FH; Richardson, FC; Swenberg, JA; Tyeryar, LA, 1987
)
0.27
" No dose-response was detected between O(4)-etT formation and smoking dose."( Smoking-related O4-ethylthymidine formation in human lung tissue and comparisons with bulky DNA adducts.
Anna, L; Gyorffy, E; Kovács, K; Nair, J; Schoket, B, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (55.56)18.7374
1990's1 (5.56)18.2507
2000's2 (11.11)29.6817
2010's5 (27.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.90 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]